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Introduction: Mechanical loads can regulate cell proliferation and differentiation at various stages of development
and homeostasis. However, the extension of this regulatory effect of mechanical loads on cancer cells is largely
unknown. Increased physical compliance is one of the key features of cancer cells, which may hamper the
transmission of mechanical loads to these cells within tumor microenvironment. Here we tested whether brief daily
application of an external low magnitude mechanical stimulus (LMMS), would impede the growth of MDA-MB-231
aggressive type breast cancer cells in vitro for 3 wks of growth.
Methods: The signal was applied in oscillatory form at 90 Hz and 0.15 g, a regimen that would induce mechanical
loads on MDA-MB-231 cells via inertial properties of cells rather than matrix deformations. Experimental cells were
exposed to LMMS 15 min/day, 5 days/week in ambient conditions while control cells were sham loaded. Cell
proliferation, viability, cycle, apoptosis, morphology and migration were tested via Trypan Blue dye exclusion, MTT,
PI, Annexin V, Calcein-AM and phalloidin stains and scratch wound assays.
Results: Compared to sham controls, daily application of LMMS reduced the number and viability of cancerous
MDA-MB-231 cells significantly after first week in the culture, while non-cancerous MCF10A cells were found to be
unaffected. Flow cytomety analyses suggested that the observed decrease for the cancer cells in the LMMS group
was due to a cell cycle arrest rather than apoptosis. LMMS further reduced cancer cell circularity and increased
cytoskeletal actin in MDA-MB-231 cells.
Conclusion: Combined, results suggest that direct application of mechanical loads negatively regulate the
proliferation of aggressive type cancer cells. If confirmed, this non-invasive approach may be integrated to the
efforts for the prevention and/or treatment of cancer.
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Cancer, one of the leading causes of death worldwide, is
characterized by the uncontrolled growth of cells that
eventually leads to disruption of tissue organization and
function [1]. Since no universal treatment is available for
cancer other than remedies that kill rapidly dividing cells
at the expense of life quality [2-5], prevention strategies
are often emphasized for the practice of healthy lifestyle
choices such as following a healthy diet, minimizing sun* Correspondence: enginozcivici@iyte.edu.tr
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article, unless otherwise stated.exposure and cessation of substance addictions [6]. One
of those healthy choices is to avoid a sedentary lifestyle,
and indeed a negative correlation exists between the
levels of physical activity and rate of incidence for cancer
[7-11]. Increased physical activity is associated with re-
duced incidence rates of colon, breast, prostate, endomet-
rial and lung cancers [7,8,12,13]. Suggested mechanisms
for reduced cancer incidence mainly focus on the global
effects of exercise on body fat mass, hormonal or immune
status [12], but recently interaction of mechanical loads
with cancer cells received further attention [14-16].
Mechanical loads are omnipresent in all tissues and they
act as an important modulator of cellular machineryentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Experimental design calendar for the application
of sham signal or low magnitude mechanical stimulus
(LMMS) to MDA-MB-231 breast cancer cells
D(-1) D0 D1 D2 D3 D4 D5
○ ○ X,† X X,† X X,†
D6 D7 D8 D9 D10 D11 D12
○ ○ X X,† X X X,†
D13 D14 D15 D16 D17 D18 D19
○ ○ X X X X X,†
X, LMMS/Sham; ○, Rest; †, Evaluation.
After plating cells on D(-2), LMMS or sham signal was applied starting from D1
until D19, 15 min/day, 5 days/week. Cultures were terminated on selected days
for the evaluation of cellular indices.
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[17-20]. Cellular decisions such as growth, migration and
differentiation are dependent on mechanical loads, and
the absence of these loads induces catabolism and mal-
formation in many tissue types. Taking advantage of the
regulatory and anabolic potential of mechanical stimuli,
daily physical exercise is protective against diseases that
are detrimental to tissue integrity [21-23]. Though cellular
response to mechanical loads in healthy and diseased tis-
sue types were addressed frequently in the literature [24],
how cancerous cells respond to mechanical loads and
whether they are exempt from the regulatory effects of
mechanical loads is largely unknown.
Many cancer types present themselves with a tumor
formation, a structure that is significantly stiffer compared
to the surrounding healthy tissue [25]. The stiffness of
tumor tissue is governed by the aberrant extracellular
matrix deposited by the cancer cells. In contrast, cancer
cells that lie within the tumor tissue are more compliant
compared to healthy cells as evidenced by single cell
mechanical manipulation techniques [26]. Cancer cells
can readily utilize their “more compliant state” for an
increased efficacy for invasion and migration to distant
sites [27]. Other than a small fraction (<6%) of cases that
are formed as mucinous tumors [28] breast cancer is no
exception to stiff extracellular matrix and compliant cell
composition [29]. From a mechanical perspective, the
composition of an extracellular matrix that is stiffer, and
cells that are softer than a healthy tissue suggests that
breast cancer cells may also be protected from mechanical
loads in a manner that is similar to the event of “stress
shielding” seen in orthopedic biomaterial applications
[30,31]. In a composite structure stiffer elements ab-
sorb larger loads compared to compliant elements. Even
though cancer cells are known to be responsive to mech-
anical cues [32,33], if they are protected from global loads
within stiffer tumors, then potential regulatory effects of
these loads on cancer cells may not be able to potentiate
in the first place.
Alternative to external loads that are prescribed to tis-
sues and shared between extracellular matrix and cells,
accelerations can be used to generate mechanical loads
on the cells based on Newton’s 2nd law of motion. In such
a system, accelerations would prescribe mechanical loads
on every element of the system based on the mass of indi-
vidual elements. These repeated oscillatory loads need not
to be large in magnitude, as healthy tissues and cells can
sense and respond to these loads that are at least two or-
ders of magnitude smaller compared to mechanical loads
that are associated with regular weight bearing [34-36].
Here we tested whether direct application of low magni-
tude mechanical stimuli (LMMS) would be detrimental to
the proliferation and invasiveness of aggressive type hu-
man breast cancer cells.Materials and methods
All experiments were conducted in compliance with
ethical board of Izmir Institute of Technology. MDA-
MB-231 (American Type Culture Collection, VA, USA)
aggressive type breast cancer cells were used throughout
the study. Briefly, cells were cultured using DMEM with
high glucose (Thermo Scientific HyClone, UT, USA)
supplemented with 1% Pen/Strep (Biological Industries,
Israel) and 10% FBS (Biological Industries, Israel). MCF10A
(American Type Culture Collection, VA, USA) human
breast epithelial cells were used as non-cancerous epithe-
lial controls. MCF10A cells were cultured in DMEM:F12
medium (Sigma, MO, USA) supplemented with 20 ng/ml
EGF (Sigma, MO, USA), 0.5 ug/ml hydrocortisone (Sigma,
MO, USA), 100ng/ml choleratoxin (Sigma, MO, USA),
10 ug/ml insulin (Sigma, MO, USA), 1% Pen/Strep (Bio-
logical Industries, Israel), 5% donor equine serum and 2
mM L-glutamine. Cells were kept in 37°C and 5% CO2 ex-
cept vibratory loading protocol, during which they were
exposed to the ambient conditions. For all experiments
cells were cultured in 24 well plates (Corning, NY, USA)
with a 640 cells/mm2 density to prevent overpopulation
during 3 wks and culture medium was changed every two
days. For all experiments, day of plating was considered as
day (-2) and cultures were maintained for a range of days,
including D1, D3, D5, D9, D12 and D19 (Table 1). At the
designated time points, experiments were terminated for
further analysis.
Experimental cells were exposed to a daily regimen of
mechanical vibration at 90 Hz and 0.15 g (1 g = Earth’s
gravitational pull), for 15 min/day, 5 days/week in am-
bient conditions, during which control plates were sub-
jected to sham loading. Mechanical signal was provided
by a custom-made platform in vertical direction [37],
and the mechanical signal quality was continuously
controlled with real-time accelerometer (K-Beam, Kistler,
Amhers, NY, USA), measurements monitored by Labview
2010 Signal Express (National Instruments, Austin, TX,
USA) software.
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were quantified using trypan blue exclusion method,
where cells were diluted with 0.4% trypan blue dye (Gibco,
Invitrogen, NY, USA) dye in 1:1 ratio and counted with a
Neubauer hemocytometer. Cell viability was analyzed via
MTT assay, in which cells were incubated with 0.5mg/ml
MTT (Amresco LLC, OH, USA) for 4 hours. After the in-
cubation tetrazolium salts were dissolved in DMSO and
colorimetric measurements was done at 570 nm with a
background subtraction at 650 nm. Cellular morphology
and actin ultrastructure was visualized using phalloidin
(Invitrogen, USA) staining followed by analysis of individ-
ual cells using Image J software.
Experimental and control groups were subjected to cell
cycle analysis based on the DNA content of the cells via
propidium iodide (PI) staining. Briefly, cells were collected
in 1x cold PBS solution and then fixed with EtOH. After
overnight incubation at -20°C, cells were permeabilized
with 0.1% Triton x-100 in PBS and treated with RNase A.
Finally, cells were incubated with PI and analyzed with
FACS Canto (BD Biosciences, CA, USA) with low flow
rate. Based on binomial distribution of PI signal gating
and doublet distinction was done according to the area of
the signal peaks with a cell cycle analysis software (Modfit
LT, Verity Software, USA). Fractions of apoptotic, live and
dead cells were quantified using Annexin V – PI (BD
Pharmingen, NJ, USA) staining based on the specifications
instructed by the provider. Briefly, collected cells were
washed twice with PBS then suspended in binding buffer
and stained with Annexin V (FITC) and PI dyes. Cells
were analyzed with FACS Canto where single stain and
unstained cells were used to set event gates. Calcein-AM
cell permeant dye (Life Technologies, Oregon, USA) was
used to stain MDA-MB-231 cell at days D5, D12 and D19,
with 30 min incubation in the dark, followed by cell de-
tachment and flow cytometry measurements.
Cellular morphology and actin ultrastructure was doc-
umented with phalloidin (Alexa Fluor 488, Invitrogen,
USA) staining after cellular fixation (4% paraformalde-
hyde) and membrane permeabilization (0.1% TritonX in
PBS). Images were acquired by fluorescence microscopy
(CKX71, Olympus, Japan) and processed with an image
processing software (Image J, USA). Scratch closure
rates for both groups were quantified using an artificial
scratch mark made with the tip of a 200 μl pipette. Scrat-
ches were visualized immediately and after 24 hrs of incu-
bation for both groups using a microscope (CKX41,
Olympus, Japan) with image processing software (DP2-
BSW, Olympus, Tokyo, Japan). The gap between cells was
measured from 3 different regions on a single scratch, re-
peated 10 times within sample. The percent change of
average gap length between 0 and 24 hrs was reported as
an indicator of gap closure. Mechanical signal was not ap-
plied to cells during this 24 hrs period.All results were reported as mean (±standard devi-
ation). Groups were compared using Student’s t test with
unequal variance where statistical significance was set at
5%. For all experiments described above, a minimum of
3 replicates were used from both groups, except cell de-
tachment and calcein stains.
Results
During 19 days of culture a steady increase was observed
in sham control MDA-MB-231 cells as measured with
Trypan Blue cell counts. At the end of 19 days, on aver-
age number of cells increased 108-fold compared to
baseline controls (Figure 1a). Number of low magnitude
mechanical stimulation (LMMS) treated cells also showed
a steady increase during experimental period with an aver-
age increase of 92-fold compared to baseline controls.
LMMS group had 41%, 32% and 18% (all p < 0.05) less
number of MDA-MB-231 cells at D9, D12 and D19 com-
pared to controls. Similar to Trypan blue readings, cell
viability signals of MDA-MB-231 as documented with
MTT assays for sham control cells showed a steady in-
crease during the experimental protocol (Figure 1b). At
D19 MTT signal showed 25-fold increase compared to
baseline controls. Compared to sham controls, LMMS
treated cells showed 62%, 18% and 50% (all p < 0.05) less
MTT signal during D5, D9 and D19, respectively. To test
if the reduced number of cells in LMMS groups observed
because of cellular detachment from culture plate, cells in
collected media was counted for both groups using Try-
pan blue stain (Figure 1c). No significant differences
(all p > 0.1) were detected for number of detached cells in
experimental days (Figure 2c). In spite of observed re-
duction in cell numbers for breast epithelial cancer cells
(MDA-MB-231), similar loading with LMMS affected
non-cancerous breast epithelial cells (MCF10A) differently
(Figure 1d). At the D5, LMMS group had 8% more MTT
activity (p < 0.01) compared to controls. At D12 and D19,
MTT activity of MCF10A cells in LMMS group had a
non-significant 6% and 1% (p = 0.20 and 0.55, respectively)
difference compared to sham controls.
In an effort to explain the reduction of cell numbers
and viability in LMMS treated cultures, cell cycle ana-
lysis was performed using PI staining. Unfortunately,
cultures from both sham control and LMMS groups at
D1, D3 and D5 lacked enough number of cells for ana-
lysis therefore cultures from D9, D12 and D19 were re-
ported here. At D9, LMMS group had 3% (0.03) more
fraction of cells in G1 phase while 24% (p = 0.03) less
fraction of cells in G2 phase compared to sham con-
trols (Figure 2a and b). At D12, LMMS group had 18%
(p = 0.02) less fraction of cells in G2 phase. In contrast
to previous time points, LMMS treated cells at D19
had 3% (p = 0.05) less fraction of cells at G1, while
27% (p = 0.05) more fraction cells in G2 compared to
Figure 1 Cell proliferation measurements of MDA-MB-231 cells for control and LMMS groups assessed with a) Trypan Blue dye exclusion
method b) MTT assay. c) Number of MDA-MB-231 cells that were detached from the plastic counted by Trypan Blue stain. d) Cell proliferation of
MCF10A cells assessed with MTT assay. (*: p < 0.05 between LMMS and sham controls).
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fraction of cells that are in S phase between LMMS and
controls for the duration of experiment (Figure 2c).
Control and LMMS cells were stained with Annexin
V – PI documented for the apoptotic status of experi-
mental cells (Figure 3a). No difference (all p > 0.15) in
the fraction of apoptotic cells were observed between
control and LMMS groups (Figure 3d). Fraction of
dead cells in LMMS group was 51% (p < 0.01) and 28%
(p = 0.05) larger at D12 and D19 compared to controls
(Figure 3b). At D12, fraction of live cells had small but a
significant reduction (1.1%, p < 0.01) compared to con-
trol cells (Figure 3c). Furthermore, fraction of live cellsFigure 2 MDA-MB-231 cell cycle assessment showing cell fractions fo
and c) S phase, represented based on experimental days 9, 12 and 19. (*: pat D12 showed a similar reduction (3%, p = 0.02) as de-
termined by Calcein-AM staining (Table 2).
The effect of LMMS on the morphology and ultra-
structure of MDA-MB-231 cells were determined by
fluorescence microscopy (Figure 4a and b). At D1 no
significant difference was observed in individual cellular
area, cellular circularity and actin content (Figure 4c-e).
However at the end of first week cancer cells that re-
ceived daily LMMS had 32% (p = 0.02) stronger fluoresce
signal with 12% (p = 0.04) smaller circularity compared
to control cells. Migratory potential of MDA-MB-231
increased with the confluence during the experimental
protocol as evidenced by 24 hrs scratch closure rates.r control and LMMS groups that were in a) G1 phase, b) G2 phase
< 0.05 between LMMS and controls).
Figure 3 MDA-MB-231 apoptosis/necrosis assessment with Annexin V – PI stains of control and LMMS groups for different
experimental days. a) Representative gates applied for all samples determining dead, live and apoptotic cells. Fractions of b) dead cells (PI+),
c) live cells (No stain) and d) apoptotic cells (Annexin V+, PI-) (*: p < 0.05 between LMMS and controls).
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scratch closure significantly for the time points
analyzed (Figure 5).
Discussion
The ability of low magnitude mechanical signals (LMMS)
to interfere with the growth, viability, cell cycle, apoptosis
and migration potential of MDA-MB-231 aggressive type
breast cancer cell was investigated in vitro for 3wks dur-
ation. MDA-MB-231 cells showed a steady proliferation
rate during the extension of the study. Daily application of
LMMS reduced number of breast cancer cells at different
time points, but did not affect non-cancerous controls.
According to the cell cycle analysis, LMMS reduced the
fraction of cancer cells that are cycling and arrested them
in either G1 or G2 phase. However, LMMS neither inter-
fered with the migratory potential nor induced apoptosisTable 2 Calcein-AM staining of MDA-MB-231 breast
cancer cells at different experimental days
D5 D12 D19
Control 93.3 ± 1.4 92.1 ± 1.0 92.8 ± 1.2
LMMS 94.7 ± 1.4 89.5 ± 1.2* 93.5 ± 0.6
(*: p < 0.05).in MDA-MB-231 cells. Reported results indicate that the
application of LMMS to breast cancer cells may suppress
the uncontrolled growth, emphasizing a potential thera-
peutic benefit against the disease.
Implementation of LMMS for 15 min/day on MDA-
MB-231 cells decreased number of cycling cells in short-
term. Colon cancer cells show a similar cell cycle arrest
at G1 when exposed to mechanical loads in shear form
[38], perhaps signifying a global pattern for the mecha-
nical regulation on cancer cells. Similarly, MCF-7 breast
cancer cells cycle more and show increased proliferation
during space-flight [39], a condition that induce constant
unloading to cells [40]. Further, constant weightlessness
on thyroid carcinoma cells is associated with events that
increase extracellular matrix formation, metastatic spread
with the inhibition of apoptosis [41]. Combined, these
data emphasize that future studies should identify the
mechanical regulation on the molecular mechanisms of
cancer cell cycle and whether brief exposure to daily phys-
ical stimulus can impede the growth of other tissue types
of cancer.
The stimulus that was investigated here was largely
tested in vivo for the anabolic effects in skeletal tissue dur-
ing and after mechanical unloading [42], for suppression
Figure 4 Phalloidin staining and morphology of MDA-MB-231 cells for control and LMMS groups for experimental days 1 and 5.
Representative micrographs from a) control and b) LMMS group. Individual cells were analyzed for c) mean green intensity, d) cellular area and
e) cellular circularity. (*: p < 0.05 between LMMS and controls).
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induced obesity and for normalization of hematological
function in bone marrow hampered by obesity [45]. None
of those studies reported any adverse effects of LMMS on
the tissues studied within. Recently, Pagnotti et al used a
similar daily loading regimen on a mouse model of spon-
taneous granulosa cell ovarian cancer and showed a bene-
fit to skeletal health without compromising the longevity
of the organism [46]. These results are important inFigure 5 Scratch closure rates (%) of MDA-MB-231 cells for
control and LMMS groups for the duration of 24 hours
represented based on experimental days 5, 9, 12 and 19.describing that low magnitude mechanical stimulus is
advantageous to tissues that are threatened with sev-
eral disease states without benefiting the progression
of cancer. Even though LMMS failed to improve the
survival rate of mice from ovarian cancer, tissue based
results in vibrated mice were suggestive for lower tumor
incidence that involved fewer organ systems [46], suggest-
ing that LMMS may interfere with the initiation but not
the progression of cancer. In order to improve the pre-
ventive and/or inhibitory potential of LMMS, perhaps the
signal is required to be optimized for bouts, amplitude
and frequency based on tissue and/or cancer type.
Our results suggested that mechanical loads have a
direct effect on the growth of cancer cells however the
hypothesis that mechanical regulation on cancer cells
would be obstructed by the physical compliance of these
cells requires further testing. Increased compliance is a
hallmark of cancer types of various tissues including
breast [47], bladder [48], leukemia [49], ovarian [50], gas-
trointestinal [51] and lung [52] cancers. Cancer cells that
show the highest potential for invasion are the cells with
the highest compliance [27]. Metastatic capacity is also in-
versely related to the adhesion strength as metastatic cells
lose adhesive properties to the extracellular matrix [53].
Altered physical properties of whole cancer cells therefore
should be permissive towards under- or un-loading from
the physical loads that are omnipresent in tissues. Consist-
ent with the hypothesis that cancer cells are exposed to
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shown to have reduced force interactions with each other
and their environment [54]. As mechanical forces influ-
ence numerous functions in cells [55], the ability of cancer
cells to mitigate this influence may affect their survival,
proliferation and invasion.
Though we hypothesized a direct link between mech-
anical loads and cancer cell proliferation, other factors
need to be addressed that may compliment or solely
dominate the relationship between exercise and cancer.
For example, exercise decreases adipose mass, a tissue
that can store carcinogens [56-59] and therefore increase
the risk for cancer. Further, fat mass is a determinant of
fertility, which presents another risk factor for cancer in
females [60]. Exercise also lowers circulating levels of in-
sulin, which may act as a growth factor that enhance cell
proliferation and inhibit cell death [61,62]. Lastly, exer-
cise augments immune function [63,64], which may in
turn increase an organism’s capability to determine and
kill cancerous cells. Direct involvement of mechanical
loads in determining the fate of cancer cells may act in
tandem with the anti-carcinogenic repertoire that mech-
anical loads can foster.
Conclusion
This study serves as a proof-of-principle that regular ap-
plication of brief daily mechanical stimulus negatively af-
fects the uncontrolled growth of aggressive type breast
cancer cells in vitro. Although the mechanisms pertain-
ing to this interaction remains largely elusive, follow up
studies warrant further attention to regulation of mo-
lecular mechanisms in cancer cells by mechanical loads.
If indeed mechanical loading of cancer cells by oscilla-
tory motions is effective in reducing the growth of can-
cer, this non-invasive approach may be utilized alone or
complementary with other therapies to combat against
different types of cancer in clinic.
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